Rchr
J-GLOBAL ID:201801000727900169
Update date: Jan. 23, 2025 Asaoka Tadafumi
アサオカ タダフミ | Asaoka Tadafumi
Affiliation and department: Job title:
Osaka Police Hospital
Research field (1):
Digestive surgery
Research theme for competitive and other funds (3): - 2019 - 2022 移植・再生医療に向けた肝・膵組織の三次元立体構築
- 2015 - 2019 Regulating liver regeneration and hepatocyte tumor proliferation in modulating intracellular signal transduction
- 2015 - 2018 Research on personalized medicine against treatment-resistant liver cancer from the viewpoint of epithelial-Mesenchymal Transition and hierarchical replication ability
Papers (229): -
Hiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, Yoshito Tomimaru, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Tadafumi Asaoka, Takehiro Noda, et al. ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Patients with Pancreatic Cancer, and Enhances Radioresistance. Annals of surgical oncology. 2024
-
Hiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, et al. miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. Annals of surgical oncology. 2024
-
Hiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, Tetsuhisa Kitamura, Shogo Kobayashi, Yoshito Tomimaru, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, et al. Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2024
-
Daisaku Yamada, Yu Takeda, Hidenori Takahashi, Kazuki Sasaki, Yoshifumi Iwagami, Yoshito Tomimaru, Takehiro Noda, Shogo Kobayashi, Tadafumi Asaoka, Junzo Shimizu, et al. Preoperative nutritional status is a useful predictor of the feasibility of postoperative treatment in octogenarian-plus pancreatic ductal adenocarcinoma patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2024. 50. 12. 108650-108650
-
Hiroki Ueda, Hidenori Takahashi, Hirofumi Akita, Yoshito Tomimaru, Shogo Kobayashi, Masahiko Kubo, Yousuke Mukai, Reishi Toshiyama, Kazuki Sasaki, Shinichiro Hasegawa, et al. Prognostic impact of aberrant right hepatic artery involvement in patients with pancreatic cancer: A multicenter retrospective cohort study. Journal of surgical oncology. 2024. 130. 3. 504-515
more... MISC (26): -
Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Tadafumi Asaoka, Yasuo Urata, Kentaro Kishi, Daisaku Yamada, Shogo Kobayashi, Hidetoshi Eguchi. Development of modified telomerase-specific adenovirus-based identification for viable-peritoneal tumor cells in peritoneal lavage fluid in resectable pancreatic cancer. CANCER RESEARCH. 2022. 82. 12
-
Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Tadafumi Asaoka, Yasuo Urata, Kentaro Kishi, Daisaku Yamada, Shogo Kobayashi, Hidetoshi Eguchi. Development of modified telomerase-specific adenovirus-based identification for viable-peritoneal tumor cells in peritoneal lavage fluid in resectable pancreatic cancer. CANCER RESEARCH. 2022. 82. 12
-
Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Yusuke Matsuura, Kenichi Matsumoto, Tadafumi Asaoka, Yasuo Urata. Viable circulating tumor cells predict occult metastatic disease and prognosis, and aberrant expression of PD-L1 on viable CTC in pancreatic cancer. CANCER RESEARCH. 2021. 81. 13
-
宮崎 葉月, 浅岡 忠史, 花木 武彦, 岩上 佳史, 秋田 裕史, 野田 剛広, 後藤 邦仁, 小林 省吾, 川崎 桂輔, 森井 英一, et al. 経過観察中に浸潤癌の合併を認めた胆管内乳頭状腫瘍の1切除例. 胆道. 2020. 34. 4. 748-757
-
Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Tadafumi Asaoka, Yasuo Urata, Kentaro Kishi. Clinical impact of new liquid biopsy using modified telomerase-specific adenovirus-based identification for viable-peritoneal tumor cells in peritoneal lavage fluid in resectable pancreatic cancer. CANCER RESEARCH. 2020. 80. 16
more... Return to Previous Page